Recognition for Leadership in Life Sciences
David Benshoof Klein, the founder and chief executive officer of Click Therapeutics, has gained notable recognition as a winner in the esteemed PharmaVoice 100 list. This annual honor is awarded to extraordinary influencers within the life sciences sector, celebrating their contributions to evolving healthcare.
Innovative Approach to Digital Therapeutics
Klein has spent more than two decades in the life sciences field, establishing himself as a leader in healthcare innovation. His vision focuses on ensuring that prescription digital therapeutics meet rigorous development standards, leading to safer and more effective treatments for patients. He is a firm believer in the potential of combining technology and pharmaceuticals to revolutionize patient care and create a more accessible healthcare system worldwide.
A Commitment to Advancing Patient Outcomes
Expressing his gratitude for the recognition, Klein stated that receiving this honor from PharmaVoice affirms the collective efforts of his innovative team at Click Therapeutics. He emphasized the importance of digital therapeutics in filling gaps in care and enhancing patient health outcomes.
A Look Into PharmaVoice 100 Selection Process
The PharmaVoice 100 winners are handpicked from a large pool of nominations submitted by peers in the industry, evaluated meticulously by the PharmaVoice team. The honorees are organized into 10 categories, such as Standout Leaders and Cancer Care Visionaries, each representing significant advancements within the pharmaceutical field.
The Value of Recognition in Healthcare
The winners of this prestigious list are viewed as inspirations within their respective organizations. Their leadership roles propel their teams toward progress, supporting patients and guiding their organizations with purpose. Meagan Parrish, the lead editor of PharmaVoice, describes these honorees as critical figures driving advancements in science and technology that foster a healthier future for everyone.
Inclusive Recognition Across the Industry
Comprising individuals from diverse sectors within life sciences—from startups to established big pharma—the PharmaVoice 100 list uniquely spotlights those making substantial impacts in their fields. This recognition includes contributions from professionals across various levels, reinforcing the notion that innovation thrives in collaboration.
About Click Therapeutics' Mission
Click Therapeutics, Inc. is at the forefront of developing, validating, and commercializing software-based prescription medical treatments. The company specializes in Digital Therapeutics™, delivering FDA-regulated, clinically validated treatments directly to users' smartphones. This innovative approach is anchored in a commitment to technical excellence, scientific rigor, and a strong focus on patient-centric design processes.
Groundbreaking Developments in Mental Health
In collaboration with Otsuka, Click Therapeutics launched Rejoyn™, the first prescription digital therapeutic approved by the FDA for treating symptoms of major depressive disorder. The company continues to broaden its therapeutic offerings, targeting various healthcare needs, including areas like neurology and oncology, leveraging advanced technologies such as artificial intelligence and machine learning.
A Fostering Environment for Innovation
Recognized consistently as a top employer, Click Therapeutics cultivates a diverse and inclusive environment, where a vast array of professionals—from clinicians to technologists—unite to improve patient access to effective prescription digital therapeutics.
Frequently Asked Questions
What is the PharmaVoice 100 list?
The PharmaVoice 100 list honors influential figures in the life sciences industry for their remarkable contributions and leadership.
Who is David Benshoof Klein?
David Benshoof Klein is the founder and CEO of Click Therapeutics and a prominent innovator in the life sciences field.
What does Click Therapeutics specialize in?
Click Therapeutics develops software-based prescription medical treatments known as Digital Therapeutics™, aiming to bridge gaps in healthcare.
Why is digital therapeutics important?
Digital therapeutics offer innovative solutions to traditional treatments, improving accessibility and addressing unmet medical needs.
How does PharmaVoice select its honorees?
PharmaVoice selects its honorees based on nominations from the industry, which are evaluated by its editorial team and categorized into distinct groups.
